TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
VANI

Vivani Medical Inc.

Healthcare · Biotechnology

1.20$ -3.1% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet VANI
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
97.5% 94.7% 90.9% 90.8% 90.1% 79.0% 46.6% 45.3% 93.0% 50.4% 49.2% 45.4%
1.4% 56.5% 64.7% 4.2% 41.9% 68.2% 39.9% 39.9% 88.2% 45.1% 44.2% 41.2%
80.4% 56.5% 64.7% 54.1% 41.9% 68.2% 39.9% 39.9% 88.2% 45.1% 44.2% 41.2%
1.6% 5.3% 1.6% 12.6% 4.7% 2.7% – – – – 0.6% 1.7%
13.3% 29.1% 20.3% 18.6% 30.4% 6.2% – – – – – –
– – – – – – 3.3% 6.3% – – – –
19.6% 28.3% 33.7% 45.6% 71.1% 56.2% 62.6% 54.8% 13.3% 54.7% 57.6% 60.1%
19.6% 28.3% 33.7% 45.6% 71.1% 41.9% 41.9% 38.3% 13.3% 12.5% 14.4% 16.8%
– – – – – 1.4% 26.6% 16.7% 1.9% 3.0% 3.2% 4.6%
1.2% 2.5% 6.9% 5.2% 12.2% 6.6% 4.3% 5.2% 2.3% 1.2% 2.0% 2.6%
80.4% 71.7% 66.3% 54.4% 28.9% 43.8% 37.4% 45.2% 86.7% 45.3% 42.4% 39.9%
-354.5% -611.3% -1,224.5% -1,616.7% -2,522.7% -1,836.2% -884.1% -1,080.1% -142.4% -214.9% -293.4% -377.1%
7.9% 17.3% 32.9% 49.0% 80.5% 94.1% 538.7% 664.8% 74.8% 111.0% 132.3% 158.4%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?